Exosect to provide first insight into Entostat liquid based foliar application

Latest formulation research for a contact insecticide to be presented at Crops & Chemicals Europe
WINCHESTER, U.K. - Feb. 8, 2016 - PRLog -- Winchester, UK – Exosect Ltd., today announced that it will share details about an exciting new liquid foliar application based on its proprietary formulation delivery platform, Entostat, with delegates at this week’s Crops & Chemicals conference in Berlin.

Tightening regulatory controls have led to a significant increase in the cost of discovery and development of new synthetic molecules.  In response, the industry has refocussed R&D expenditure into two key areas; discovery or acquisition of biological active ingredients and reformulation of existing synthetic active ingredients as single or dual formulations.

According to Phillips McDougall the number of new molecules in development in the agrochemical sector has almost halved since the year 2000[1].

Both avenues of development pose formulation challenges as the next generation of synthetic pesticides and biopesticides seek to achieve the delicate balance between reduced chemical inputs whilst at the same time maintaining or improving efficacy. Exosect can address this challenge through more accurate and precise delivery.

At Crops & Chemicals Europe on Wednesday, Dr. Aoife Dillon, Chief Technology Officer at Exosect, will be presenting the first exciting results into this liquid based foliar application, specifically focussing on delivery of contact insecticides as a model system.

Dr. Aoife Dillon comments, “Over the last fifteen years we have developed extensive know-how on the Entostat platform and delivery of a liquid formulation significantly broadens the scope of our platform technology. The industry is seeking to reformulate Active Ingredients in order to extend product life, develop new Intellectual Property and enter new markets. The key to this challenge is innovation in formulation. I am looking forward to presenting our insights into the capabilities of Entostat.”

- Ends -

Notes to Editors

Entostat is an electrostatically charged micro-powder. A leading variant of Entostat is based on a carnauba wax blend that is chemically inert.

This variant of Entostat is sustainably harvested from the Brazilian Carnauba palm, Copernica martius (Palmae). Other variants include a range of natural and synthetic waxes and polymers.

Entostat is a non-hygroscopic electrostatic micro-powder that can be produced in a range of sizes and shapes. It can be formulated to matrix encapsulate synthetic active ingredients offering release retardation and to support biological active ingredients on its surface by electrostatic attraction.

Entostat readily gains an electrostatic charge, consequently it adheres to a range of surfaces including, grains and seeds, insects & animals, building fabrics.

It therefore has the potential to deliver active ingredients at a reduced application rate with equivalent or improved efficacy.

Entostat is a registered trademark of Exosect Ltd.

About Exosect

Exosect was launched in 2001 to develop proprietary platforms technologies, initially for agriculture.

The company has developed an in-depth knowledge and extensive patent portfolio of the platforms as targeted delivery mechanisms for a range of active ingredients, biological and synthetic.

Today, the technology is enabling our partners across a range of sectors to realise the efficient delivery of their active ingredients, helping them to overcome issues such as pest resistance, regulatory controls and residues within the food chain.

Exosect is focussed on the Agriculture, Public Health and Animal Health sectors.

[1] Phillips McDougall – April 2015 – AgriFutura Newsletter – No.186

Media Contact
Georgina Donovan
02380 603939
Email:***@exosect.com Email Verified
Tags:Entostat, Foliar Application, Contact insecticide
Location:Winchester - Hampshire - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Exosect News
Most Viewed
Daily News

Like PRLog?
Click to Share